摘要
目的探讨结外NK/T细胞淋巴瘤(ENTKL)合并噬血细胞综合征(HPS)(ENKTL—LAHS)的临床特征、诊断、治疗及预后。方法分析3例NK/T—LAHS患者的临床资料,并进行文献复习。结果3例ENK-TL—LAHS患者年龄均小于60岁。2例淋巴瘤初诊时具有多项不良预后因素。3例ENKTL—LAHS患者均处于淋巴瘤的治疗和进展阶段。临床表现为持续高热、2~3系血细胞进行性减低、脾肿大、肝功能异常、铁蛋白升高及高TG血症等。发生HPS后病情进展迅速,短期内合并多器官功能不全综合征或弥漫性血管内凝血而死亡。自合并HPS后生存期18—124d。结论ENKTL—LAHS多见于中青年,多发生在ENKTL的进展或复发阶段,其临床特点不典型,早期诊断困难,尚缺乏有效治疗手段,预后差。
Objective To explore the clinical features, diagnosis, treatment and prognosis of extranodal NK/T- cell lymphoma(ENKTL)associated hemophagocytie syndrome(HPS) (ENKTL-LAHS). Methods The clinical data of 3 patients with ENKTL-LAHS were retrospectively analyzed, and the related literature was reviewed. Results All the 3 patients were under 60 years old. Two of them at newly diagnosis had more than two risk factors indicating poor prognosis. All the 3 patients developed HPS at the progression or recurrence of lymphoma, and had the following clinical features : persistent high fever,2-3 hemocyte decrease, splenomegaly, abnormal liver function, increased ser- um ferritin and triglyceride. The disease progressed rapidly after onset of HPS,leading to death in a short period due to multiple organ dysfunction syndrome or disseminated intravaseular coagulation. The survival time of 3 patients after onset of HPS were 18-124 days. Conclusion ENKTL-LAHS appears most frequently at the progression or recur- rence of ENKTL, at the age less than 60 years old. Its clinical features are not typical, and the early diagnosis is difficult. The therapeutic response and prognosis of ENKTL-LAHS are extremely poor.
出处
《肿瘤基础与临床》
2015年第6期520-523,共4页
journal of basic and clinical oncology
基金
国家自然科学基金资助项目(编号:U1404833)